Cost Effectiveness of Cetuximab and Panitumumab for First-Line RAS WT Metastatic Colorecal Cancer

May 1, 2016, 00:00
10.1016/j.jval.2016.03.1612
https://www.valueinhealthjournal.com/article/S1098-3015(16)01680-6/fulltext
Title : Cost Effectiveness of Cetuximab and Panitumumab for First-Line RAS WT Metastatic Colorecal Cancer
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)01680-6&doi=10.1016/j.jval.2016.03.1612
First page : A154
Section Title : Cancer - Cost Studies
Open access? : No
Section Order : 334
Categories :
Tags :
Regions :
ViH Article Tags :